|
|
| Sunday Nov 2 | ||||||
| Short Courses | ||||||
| 9 AM - 12 PM |
LC/MS: Practical Aspects Lead: Jack Henion |
Development and Validation of Quantitative LC-MS/MS Assays for Use in Clinical Diagnostics Lead: Russ Grant |
||||
|
Introduction to Mass Spectrometry Lead: Ken Busch |
Metabolomics Lead: Gary Siuzdak |
|||||
| Noon | LUNCH | |||||
| 1 - 4 PM |
LC/MS: Practical Aspects Lead: Jack Henion |
Development and Validation of Quantitative LC-MS/MS Assays for Use in Clinical Diagnostics Lead: Russ Grant |
||||
|
Introduction to Mass Spectrometry Lead: Ken Busch |
Metabolomics Lead: Gary Siuzdak |
|||||
| 5 - 8 PM | RECEPTION IN EXHIBIT HALL | |||||
| 8 - 8:30 PM |
|
|||||
| Tuesday Nov 4 | |||
| Plenary Session Chair: Alan Rockwood |
|||
| 8:00 AM |
To Infinity, and Beyond! The Clinical Mass Spectrometry Space Don Chace |
||
| 8:45 AM |
Tools for Accurate Measurement of Candidate Biomarkers in Plasma: Development of Multiplexed MS-Based SISCAPA Assays Leigh Anderson |
||
| 9:30 AM | BREAK | ||
|
Inborn Errors in Metabolism Chair: Don Chace |
Proteins Chair: Andy Hoofnagle |
||
| 10:00 AM |
High Throughput Quantitative Analysis of Acylcarnitines and Amino Acids by MADI-Triple Quadrupole Mass Spectrometry Jay Corr |
Tumor Marker Quantification by Mass Spectrometry: First Steps with Thyroglobulin Andy Hoofnagle |
|
| 10:30 AM |
Newborn Screening by a Non-derivatized Tandem Mass Spectrometry Assay Alex Cherkasskiy |
Mapping Protein Microheterogeneity: Applications in the Development of Biomarker for Type 2 Diabetes Randy Nelson |
|
| 11:00 AM |
Newborn Screening for Congenital Adrenal Hyperplasia Using Liquid Chromatography Tandem Mass Spectrometry Mike Morris |
Development and Optimization of the Reference Measurement Procedure for HbA1C by HPLC-MS Patricia Kaiser |
|
| 11:30 AM |
Identification and Quantification of Urinary Acylcarnitines by UPLC-MS/MS Azeret Zuniga |
Plasma Renin Activity Assay by LC-MS/MS: Dude! Where's my Peptide? Cory Bystrom |
|
| Noon | LUNCH / POSTERS / EXHIBITS | ||
|
Metabolomics Chair: Gary Siuzdak |
Regulations and Standards Chair: Hubert Vesper |
||
| 3:00 PM |
Metabolomics on Stem-Cell- Based Therapy Oscar Yanes |
Mass Spectrometry in Clinical Laboratory Standardization and Routine Clinical Laboratory Applications Hubert Vesper |
|
| 3:30 PM |
The Application of a Metabolomics Dataset Toward the Understanding of Prostate Cancer Chris Beecher |
Establishing the Metrological Basis: The Work of NIST on Establishing Traceability in Laboratory Medicine David M. Bunk |
|
| 4:00 PM |
Metabolomics Reveals Large Effect of Gut Microflora on Host Biochemistry and Subsequent Activation of a Host Response Eric Peters |
Reference Laboratories and Laboratory Networks Linking the Metrological Basis to Measurement Results Maria Ospina |
|
| 4:30 pM |
A Global Peptide Profiling Approach To Identify Endogenous Peptide Substrate Interactions Alan Saghatelian |
Bad Science: The Instrumental Data in the Floyd Landis Case Robert Blackledge |
|
| 5 - 8 PM | RECEPTION IN EXHIBIT HALL / POSTERS | ||
| 8:00 PM |
|
||
| Wednesday Nov 5 | ||
|
Toxicology Chair: Alan Wu |
Metabolomics - 2 Chair: Josh Rabinowitz |
|
| 8:00 AM |
Mass Spectrometry in Toxicology: Broad Spectrum Drug Screening with Quadrupole and Ion Trap Mass Spectrometry Kara Lynch |
Using Metabolomics of Animal Models to Understand Complex Human Biochemistry and Disease William Wikoff |
| 8:30 AM |
Rapid Blood Drug Screen Using Ultra Performance Liquid Chromatography - Time of Flight Mass Spectrometry (UPLC-TOF) Scott Kriger |
Drug Target Identification Via Systems-Level Metabolic Flux Profiling Josh Rabinowitz |
| 9:00 AM |
Ion Suppression and Other Interferences in the Qualitative and Quantitative LC-MS/MS Analysis of Biological Fluids Tom Annesley |
Leucine D7 Labeling of Human C-Peptide for Assessment of Real-Time Insulin Biosynthesis: In Vivo Silac Metabolic Studies Eduard Rogatsky |
| 9:30 AM |
Drug Testing to Support Physician and Healthcare Professional Programs Alan Wu |
Metabolomics Approach for Biomarker Discovery and Diagnostic Development Don Rose |
| 10:00 AM | BREAK | |
|
Molecular Diagnostics Chair: Steve Hofstadler |
Disease Markers Chair: Ryuji Kobayashi |
|
| 10:30 AM |
Rapid Identification of Bacteria from Clinical Specimens Using MALDI-TOF MS Markus Kostrzewa |
Differential Neuroproteomics Reveal Characteristic Protein Expression Changes in Fulminant Multiple Sclerosis Jonas Bergquist |
| 11:00 AM |
High Throughput Characterization of Amplified Nucleic Acids By ESI-TOF Mass Spectrometry: Applications of the IBIS T5000 to Pathogen Detection and Characterization Steve Hofstadler |
Verification of Candidate Protein Biomarkers of Prostate Cancer by MRM Mass Spectrometry Joanna Hunter |
| 11:30 AM |
Targeted Proteomics of Influenza Viral Particles Christopher M. Colangelo |
Reference Intervals and Serum/Urine Correlation for Hepcidin 25 Reza Panahi |
| 12:00 PM |
Nucleic Acid Analysis in Microbes and Viruses by MALDI-TOF MS Christiane Honisch |
Identifying Proteolytic Peptides in Thalassemic Red Blood Cells Kai Tang |
| 12:30 PM | LUNCH WORKSHOPS | |
|
New Advances Chair: Rob Fitzgerald |
Small Molecule Analytes - 2 Chair: Russ Grant |
|
| 2:00 PM |
Driving Biological Discovery Using Separations Coupled to Mass Spectrometry John Yates |
Mass Spectrometry as an Enabling Technology in the Clinical Laboratory Nigel Clarke |
| 2:30 PM |
Overlapping MS/MS Spectra and Disease Proteomics Nuno Bandeira |
Addressing The Challenges of Throughput and Selectivity With High Resolution LC and New Scan Wave MS/MS Technology Robert Plumb |
| 3:00 PM |
Aptamers for Analyte Enrichment in Clinical Samples Sheri Wilcox |
A Comparative Study of Three Mass Spectrometric Ionization Sources to Micro-Fluidic Technology Coupled with Tandem Mass Spectrometric Method MP George |
| 3:30 PM |
Translating Basic Discoveries for Early Detection and Clinical Mangement of Skeletal Disease Darren Hillegonds |
Problems and Pitfalls of Acylcarnitine Analysis on LC/MS/MS Thomas Lynn |
| 6 - 9 PM | Reception and Mexican Fiesta Overlooking the Pacific | |